Dear All,

Welcome to the COVID-19 bulletin (number 16) from the HSE National Immunisation Office which highlights changes in clinical guidance for the COVID-19 vaccination programme.

In this edition we cover

•        Communicating the risks of very rare clotting events and Vaxzevria®

•        Dosing interval of vaccines

•        Land marking the injection site at the deltoid muscle

•        Amárach public opinion surveys on COVID-19 vaccines

•        Vaccine Effectiveness of Comirnaty® (Pfizer/BioNTech) and Vaxzevria® (AstraZeneca) vaccines in London

•        Research studies are underway comparing COVID-19 Vaccine Schedule Combinations

•        CoVax Updates

•        Website

•        COVID-19 Vaccination Training Programme

•        Do you have queries?

We also recommend you visit our website regularly to ensure you have access to the most up to date guidelines and other documents.  

We are looking for some feedback for our bulletin and other COVID-19 materials please complete our short survey.